In the rapid response to the COVID-19 epidemic, the AIAM actively engaged in the development of COVID-19 detection products, and successfully jointly developed the PG Sars-CoV-2 antibody detection reagent. Just a drop of finger blood, get the result in 3 minutes without any expensive precision equipment, professional technicians or special medical facilities. The product has recently passed the CE certification, and has completed the FDA filing application, yet pending for the approval. The accuracy rate of the antibody detection reagent exceeds 95%, which has been widely recognized. In a horizontal evaluation of 60 detection products conducted by the Brazilian National Laboratory, the accuracy rate of ours ranks among the best, and it even surpasses many nucleic acid detection reagents called the "Gold Standard" in the industry. Currently, the AIAM has been listed as designated government procurement partner by a dozens of countries in Asia, Europe and the Americas.